Team

With a rich history spanning over a decade and involvement in groundbreaking initiatives like DARPA Human Body on a Chip, NASA Tissue Chips in Space, and NIH NCATS Tissue Chip Testing Center, we have cultivated unparalleled expertise in our field. Leveraging this wealth of experience, we are dedicated to developing leading-edge technologies tailored specifically for the biopharmaceutical industry.

The Javelin Platform combines human tissue chips and digital twin software to predict how drugs will perform in humans, years before those therapeutic candidates are tested in clinical trials. From single-organ to multi-organ chips that use healthy and diseased tissues, we are building a portfolio of products to expand clients’ preclinical drug discovery capabilities to preclinical human models and AI-based translation to clinical insights, ultimately accelerating the process to bring safe and effective therapies to market faster than with existing tools and animal studies.